- €111.54m
- €88.56m
- €248.14m
- 67
- 86
- 71
- 90
Annual balance sheet for Haemato AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8.49 | 4.86 | 10.3 | 31.7 | 27.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.36 | 11.8 | 15.1 | 14.7 | 12.6 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 60.7 | 72.8 | 119 | 81.1 | 69.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.05 | 2.17 | 2.1 | 1.5 | 3.74 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 117 | 129 | 169 | 182 | 177 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25.5 | 55.5 | 42.9 | 37.1 | 26.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 40.8 | 56.3 | 43.6 | 37.3 | 29.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 75.7 | 72.2 | 125 | 145 | 147 |
| Total Liabilities & Shareholders' Equity | 117 | 129 | 169 | 182 | 177 |
| Total Common Shares Outstanding |